Jimmy Blair

Jimmy is the scientific co-founder and Head of Chemical Biology at Totus Medicines, where he pioneered the Totus hit generation engine and leads the discovery chemistry and screening team. His research is steeped in covalency, including the development of novel covalent molecules for protein kinases and the synthesis of covalent inhibitors for neglected diseases. Prior to Totus, Jimmy contributed to chemical biology and metabolomics efforts at Jnana Therapeutics, and he was a faculty member at Williams College, where he led an undergradu­ate team in the pursuit of novel antibiotics.

Jimmy holds a Ph.D. in Chemistry from UC Berkeley in Kevan Shokat’s lab and was a postdoctoral fellow at Stanford University in Lucy Shapiro’s lab.